Mupirocin ointment before a total hip or knee arthroscopy is a safe and cost-effective intervention for reducing surgical site infections, according to a study published in Infection Control and ...

A large multi-state study by the Centers for Disease Control and Prevention, the Harvard Pilgrim Health Care Institute, HCA Healthcare, and the University of California, Irvine has found that a nasal ...

The approved abbreviated new drug application (ANDA) for Mupirocin cream is therapeutically equivalent to the reference listed drug product (RLD), Bactroban cream (2 per cent) of SmithKline Beecham ...

SAN DIEGO, CA—Clinicians should consider nasal povidone-iodine as an alternative to nasal mupirocin ointment to reduce risk of deep Staphylococcus aureus surgical site infections (SSI) following ...

The study randomly selected systemic lupus erythematosus patients currently experiencing cutaneous lupus erythematosus flares to treat their skin lesions with mupirocin or with an inactive control, ...

An antibiotic ointment administered through the nose is effective in protecting critically ill patients in the ICU from Staphylococcus aureus infections, according to an Oct. 10 HCA Healthcare news ...

Systemic lupus erythematosus commonly presents as a rash. The rashes are caused by inflammation from the immune system fighting the body. Systemic lupus erythematosus, more commonly known as lupus, ...

Please provide your email address to receive an email when new articles are posted on . Impetigo is among the most common bacterial skin infections affecting infants and children, yet questions remain ...

July 21, 2008 — A survey showed a relatively high rate of mupirocin resistance in methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates, and a second study showed increasing resistance ...

Editor's note: This article, originally published on April 1, 2002, has been republished to include website enhancements. Numerous topical antiinfective products are available to your patients ...

April 6, 2012 (London, United Kingdom) — Two thirds of patients with high-level mupirocin-resistant, methicillin-resistant Staphylococcus aureus (MRSA) are receiving the wrong treatment because of an ...